BIOA vs STT · rev $9.0M vs P/E 17, rev $7.84B
BioAge Labs, Inc (BIOA) versus State Street Corp (STT) — a side-by-side from cached financials, not a winner call.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
State Street Corp (STT) is a asset management company listed on US.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
Latest reported STT revenue for 2026-06-30 was $7.84B. Net income was $1.85B. STT currently screens at market cap $45.02B and trailing P/E 16.5.
BIOA currently screens at market cap $697.9M. STT currently screens at market cap $45.02B and trailing P/E 16.5.
Not investment advice. Open the BIOA and STT stock pages for the full models.
Not investment advice.